Peripheral blood samples will be collected from individuals who have a planned lung cancer screening by LDCT and meet the protocol eligibility criteria. The blood samples and subject data will be used in Roche-sponsored studies for the development of cancer screening and detection products.
Sponsor: Roche
To learn more about the Lighthouse - Lung Cancer Screening trial, call the Reading Hospital Cancer Research Office at 484-628-8193.
